Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence.

Zhu B, Chen Y, Shen X, Liu X, Guo SW.

Reprod Biol Endocrinol. 2016 Oct 10;14(1):66.

2.

Novel Antiplatelet Activity of Minocycline Involves Inhibition of MLK3-p38 Mitogen Activated Protein Kinase Axis.

Jackson JW, Singh MV, Singh VB, Jones LD, Davidson GA, Ture S, Morrell CN, Schifitto G, Maggirwar SB.

PLoS One. 2016 Jun 6;11(6):e0157115. doi: 10.1371/journal.pone.0157115. eCollection 2016.

3.

Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.

Jenabian MA, Patel M, Kema I, Vyboh K, Kanagaratham C, Radzioch D, Th├ębault P, Lapointe R, Gilmore N, Ancuta P, Tremblay C, Routy JP.

Clin Exp Immunol. 2014 Oct;178(1):102-11. doi: 10.1111/cei.12396.

4.

Characterization of platelet-monocyte complexes in HIV-1-infected individuals: possible role in HIV-associated neuroinflammation.

Singh MV, Davidson DC, Jackson JW, Singh VB, Silva J, Ramirez SH, Maggirwar SB.

J Immunol. 2014 May 15;192(10):4674-84. doi: 10.4049/jimmunol.1302318. Epub 2014 Apr 11.

5.

Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?

Davidson DC, Jackson JW, Maggirwar SB.

J Neuroinflammation. 2013 Dec 1;10:144. doi: 10.1186/1742-2094-10-144. Review.

6.

Loss of the cytoskeletal protein Pdlim7 predisposes mice to heart defects and hemostatic dysfunction.

Krcmery J, Gupta R, Sadleir RW, Ahrens MJ, Misener S, Kamide C, Fitchev P, Losordo DW, Crawford SE, Simon HG.

PLoS One. 2013 Nov 20;8(11):e80809. doi: 10.1371/journal.pone.0080809. eCollection 2013.

7.

Valproic acid inhibits the release of soluble CD40L induced by non-nucleoside reverse transcriptase inhibitors in human immunodeficiency virus infected individuals.

Davidson DC, Schifitto G, Maggirwar SB.

PLoS One. 2013;8(3):e59950. doi: 10.1371/journal.pone.0059950. Epub 2013 Mar 28.

8.

Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders.

Davidson DC, Hirschman MP, Sun A, Singh MV, Kasischke K, Maggirwar SB.

PLoS One. 2012;7(12):e51793. doi: 10.1371/journal.pone.0051793. Epub 2012 Dec 12.

9.

Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and -B.

Refaai MA, Carter J, Henrichs KF, Davidson DC, Pollock SJ, Casey AE, Spinelli SL, Phipps RP, Francis CW, Blumberg N.

Transfusion. 2013 Feb;53(2):382-93. doi: 10.1111/j.1537-2995.2012.03718.x. Epub 2012 May 25.

10.

HIV and SIV Associated Thrombocytopenia: An Expanding Role for Platelets in the Pathogenesis of HIV.

Metcalf Pate KA, Mankowski JL.

Drug Discov Today Dis Mech. 2011 Summer;8(1-2):e25-e32. Epub 2011 Nov 9.

11.

Detection of circulating platelet-monocyte complexes in persons infected with human immunodeficiency virus type-1.

Singh MV, Davidson DC, Kiebala M, Maggirwar SB.

J Virol Methods. 2012 May;181(2):170-6. doi: 10.1016/j.jviromet.2012.02.005. Epub 2012 Feb 23.

Supplemental Content

Support Center